Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Other financing activities (2016 - 2023)

Cross Country Healthcare (CCRN) has disclosed Other financing activities for 13 consecutive years, with -$501000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Other financing activities rose 2.15% year-over-year to -$501000.0, compared with a TTM value of -$501000.0 through Mar 2024, up 51.92%, and an annual FY2023 reading of -$508000.0, up 51.43% over the prior year.
  • Other financing activities was -$501000.0 for Q2 2023 at Cross Country Healthcare, down from -$7000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $4.3 million in Q2 2021 and bottomed at -$4.2 million in Q4 2022.
  • Average Other financing activities over 5 years is $364166.7, with a median of $30500.0 recorded in 2020.
  • Peak annual rise in Other financing activities hit 3309.26% in 2022, while the deepest fall reached 375.74% in 2022.
  • Year by year, Other financing activities stood at $3.8 million in 2019, then tumbled by 98.22% to $68000.0 in 2020, then soared by 2142.65% to $1.5 million in 2021, then tumbled by 375.74% to -$4.2 million in 2022, then surged by 88.09% to -$501000.0 in 2023.
  • Business Quant data shows Other financing activities for CCRN at -$501000.0 in Q2 2023, -$7000.0 in Q1 2023, and -$4.2 million in Q4 2022.